Palisaded neutrophilic and granulomatous dermatitis associated with systemic lupus erythematosus: possible involvement of CD163+ M2 macrophages in two cases, and a review of published works.

Abstract:

BACKGROUND:Palisaded neutrophilic and granulomatous dermatitis (PNGD) is a commonly occurring condition related to systemic autoimmune disease. It is characterized histopathologically by a distinct pattern of granulomatous inflammation in the presence or absence of leukocytoclastic vasculitis. The properties of granulomatous cells in PNGD are still uncertain. OBJECTIVE:We sought further investigation on the phenotype of the infiltrated cells in PNGD from two patients with systemic lupus erythematosus (SLE) and reviewed the previous published reports in order to provide a comprehensive summary on the clinical features of PNGD in SLE. METHODS:The immunohistochemical features of granulomatous cells in PNGD associated with SLE were analyzed. Immunohistochemical studies were performed on sections from our two cases using antibodies against CD68, CD163, CD15, Factor XIIIa, myeloperoxidase and neutrophil elastase. The clinical characteristics of the SLE patients who developed PNGD were also evaluated. We included all cases retrieved through a PubMed search with the key words PNGD and SLE. RESULTS:Cutaneous lesions consisted of erythematous plaques distributed on the face and upper limbs in both cases. The infiltrated cells were mainly positive for CD68 and CD163, a phenotype suggestive of M2 macrophages. Some mature neutrophils and lymphocytes were also present. A review of the literature of PNGD associated with SLE revealed a predominance in females, high prevalence of lupus nephritis and a good response to systemic steroids, with frequent skin lesions relapses during tapering of the treatment. LIMITATIONS:This study examined only two cases; the pathogenesis of the disease remains to be clarified. CONCLUSION:PNGD lesions were abundantly infiltrated by M2 macrophages, suggesting that they may have a role in this condition. SLE accompanied by PNGD might be associated with lupus nephritis and frequent relapses of skin lesions.

journal_name

Lupus

journal_title

Lupus

authors

Terai S,Ueda-Hayakawa I,Nguyen CTH,Ly NTM,Yamazaki F,Kambe N,Son Y,Okamoto H

doi

10.1177/0961203318809892

subject

Has Abstract

pub_date

2018-12-01 00:00:00

pages

2220-2227

issue

14

eissn

0961-2033

issn

1477-0962

journal_volume

27

pub_type

杂志文章,评审

相关文献

LUPUS文献大全
  • Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.

    abstract:INTRODUCTION:The objective of this study is to determine whether serum concentrations of B cell activating factor from the tumour necrosis factor family (BAFF) and/or a proliferation-inducing ligand (APRIL) are associated with clinical manifestations of systemic lupus erythematosus (SLE). METHODS:BAFF and APRIL concen...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313496302

    authors: Vincent FB,Northcott M,Hoi A,Mackay F,Morand EF

    更新日期:2013-08-01 00:00:00

  • Syncope caused by complete heart block and ventricular arrhythmia as early manifestation of systemic lupus erythematosus in a pregnant patient: a case report.

    abstract::Systemic lupus erythematosus (SLE) can affect all heart structures including the conduction system, with either reversible or permanent derangement. However, only a few cases of adult SLE and complete atrioventricular (AV) block have been reported. We describe a young pregnant woman who initially presented with comple...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203318782425

    authors: Lo CH,Wei JCC,Tsai CF,Li LC,Huang SW,Su CH

    更新日期:2018-09-01 00:00:00

  • European registry of babies born to mothers with antiphospholipid syndrome: a result update.

    abstract::The registry is a prospective, European, multicentric, longitudinal study, which follows a cohort of children born to mothers with antiphospholipid syndrome (APS). It was started in 2003. In this report, we update the results obtained from the study of 110 mothers and 112 children (two twin births). Eighty per cent of...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203309106951

    authors: Boffa MC,Lachassinne E,Boinot C,De Carolis S,Rovere-Querini P,Avcin T,Biasini-Rebaioli C,Le Toumelin P,Aurousseau MH,Tincani A

    更新日期:2009-09-01 00:00:00

  • Annexin A2: biology and relevance to the antiphospholipid syndrome.

    abstract::Antiphospholipid antibodies (aPL), the majority of which are directed against beta(2)-glycoprotein I (beta(2)GPI), are associated with an increased incidence of venous and arterial thrombosis. The pathogenesis of antiphospholipid/anti-beta(2)GPI-associated thrombosis has not been defined, and is likely multifactorial....

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308095329

    authors: Cockrell E,Espinola RG,McCrae KR

    更新日期:2008-10-01 00:00:00

  • Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.

    abstract:OBJECTIVE:The objective of this paper is to assess whether pulmonary hypertension (PH) may be detected at one point in time or longitudinally predicted by serum uric acid (sUA) levels in systemic lupus erythematosus (SLE). METHODS:We conducted a post-hoc analysis of a long-term followed cohort of Mexican SLE patients....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600539

    authors: Castillo-Martínez D,Marroquín-Fabián E,Lozada-Navarro AC,Mora-Ramírez M,Juárez M,Sánchez-Muñoz F,Vargas-Barrón J,Sandoval J,Amezcua-Guerra LM

    更新日期:2016-01-01 00:00:00

  • Reflections on the management of reproductive failure in the antiphospholipid syndrome--the clinician's perspective.

    abstract::It is well known that women with systemic lupus erythematosus (SLE) who have antiphospholipid antibodies (aPL) are at increased risk for pregnancy loss. Additionally, other reproductive processes, such as unexplained infertility and implantation failure after in vitro fertilization and embryo transfer may be affected ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203302lu237ra

    authors: Balasch J,Cervera R

    更新日期:2002-01-01 00:00:00

  • Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus.

    abstract::Children born to women with systemic lupus erythematosus seem to have a potentially increased risk of neurodevelopmental disorders compared to children born to healthy women. Recent experimental data suggest in utero exposure to maternal antibodies and cytokines as important risk factors for neurodevelopmental disorde...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314541691

    authors: Vinet É,Pineau CA,Clarke AE,Fombonne É,Platt RW,Bernatsky S

    更新日期:2014-10-01 00:00:00

  • Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.

    abstract::In vitro data showed that immunoglobulin G (IgG) from lupus nephritis (LN) patients could bind to proximal renal tubular epithelial cells (PTEC), but the clinical relevance of such binding remained unclear. Binding of IgG and subclasses to PTEC was measured by cellular ELISA (expressed as OD index) in 189 serial serum...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315598018

    authors: Yap DY,Yung S,Zhang Q,Tang C,Chan TM

    更新日期:2016-01-01 00:00:00

  • Cerebral blood flow abnormalities in neuropsychiatric systemic lupus erythematosus.

    abstract:OBJECTIVE:To investigate the clinical characteristics, imaging changes and early diagnostic methods of neuropsychiatric systemic lupus erythematosus (NPSLE). METHODS:Thirty-five SLE patients, of which 16 had overt neuropsychiatric symptoms, underwent examination for multiple autoantibodies, including anti-double-stran...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319861677

    authors: Jia J,Xie J,Li H,Wei H,Li X,Hu J,Meng D,Zhang Y,Zhang X

    更新日期:2019-08-01 00:00:00

  • Pathogenesis of the antiphospholipid antibody syndrome.

    abstract::Endothelial and/or platelet activation likely initiates thrombus formation. Whether antiphospholipid antibody (aPL) is an activator, a toxic response, or a protective response is not clear, nor is it certain whether aPL is germ-line encoded or antigen-driven. The pregnancy model is particularly informative. Alternativ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339600500514

    authors: Lockshin MD

    更新日期:1996-10-01 00:00:00

  • Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo.

    abstract::In a 76-week, randomized controlled trial, patients received 100 mg LJP 394 or placebo weekly for 16 weeks followed by three 12-week treatment cycles of 50 mg LJP 394 or placebo weekly each separated by eight-week periods when no therapy was administered. Health-related quality of life (HRQOL) was assessed using SF-36...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1191/0961203303lu440oa

    authors: Strand V,Aranow C,Cardiel MH,Alarcón-Segovia D,Furie R,Sherrer Y,Tumlin J,Wallace DJ,Crawford B,LJP 394 Investigator Consortium.

    更新日期:2003-01-01 00:00:00

  • Cyclophosphamide for lupus during pregnancy.

    abstract::Severe systemic lupus erythematosus often requires the use of cyclophosphamide in women of reproductive age. As cyclophosphamide is generally avoided during pregnancy because of its teratogenic risk, its impact on fetal survival is poorly understood. This is a case series of lupus patients exposed to cyclophosphamide ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203305lu2169oa

    authors: Clowse ME,Magder L,Petri M

    更新日期:2005-01-01 00:00:00

  • Role of HLA in congenital heart block: susceptibility alleles in children.

    abstract::Congenital heart block (CHB) is a syndrome of uncertain pathogenesis leading to cardiac conduction disturbances in the foetus and newborns. It has been proposed that maternal antibodies transmit immunological injury in the developing foetal heart, thus causing irreversible damage of the atrioventricular node, leading ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120399678847407

    authors: Sirén MK,Julkunen H,Kaaja R,Ekblad H,Koskimies S

    更新日期:1999-01-01 00:00:00

  • The anti-thrombotic effects of vitamin D and their possible relationship with antiphospholipid syndrome.

    abstract::The importance of the immunomodulatory effects of vitamin D has recently been associated with autoimmune and chronic inflammatory diseases. Vitamin D deficiency has been linked to the development of autoimmune conditions. Antiphospholipid syndrome is an autoimmune disease characterized by thrombotic events and obstetr...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203318801520

    authors: García-Carrasco M,Jiménez-Herrera EA,Gálvez-Romero JL,Mendoza-Pinto C,Méndez-Martínez S,Etchegaray-Morales I,Munguía-Realpozo P,Vázquez de Lara-Cisneros L,Santa Cruz FJ,Cervera R

    更新日期:2018-12-01 00:00:00

  • The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review.

    abstract::Pericardial effusions causing pericardial tamponade are rare in patients with systemic lupus erythematosus (SLE). The goal of this study is to describe in detail the clinical and laboratory characteristics of a group of patients with pericardial effusions and pericardial tamponade secondary to SLE. We retrospectively ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203308100659

    authors: Rosenbaum E,Krebs E,Cohen M,Tiliakos A,Derk CT

    更新日期:2009-06-01 00:00:00

  • Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention.

    abstract::Systemic lupus erythematosus (SLE) is an autoantibody and immune complex mediated disease. However, it is the ensuing inflammatory process that leads to irreversible organ damage. In fact several murine models of SLE suggest that this inflammatory organ damage can be prevented even in the presence of autoantibodies. G...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/0961203303lu1024oa

    authors: Aringer M,Smolen JS

    更新日期:2004-01-01 00:00:00

  • Autoimmunity and heavy metals.

    abstract::This brief review is focused on those heavy metals (cadmium, gold and mercury) that have strong associations with autoimmunity. Cadmium treatment of rats and mice results in autoimmune responses that vary with species and inbred strain of animals. However, there is no solid evidence demonstrating that the renal pathol...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339400300604

    authors: Bigazzi PE

    更新日期:1994-12-01 00:00:00

  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1.

    abstract::Renal involvement is one of the main complications of systemic lupus erythematosus, causing a significant impact on patients' morbidity and mortality. Renal biopsy is still the gold standard of diagnosis, but it has many limitations. In this sense, several recent studies aim to identify biomarkers that not only predic...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203319826695

    authors: Gasparin AA,Pamplona Bueno de Andrade N,Hax V,Tres GL,Veronese FV,Monticielo OA

    更新日期:2019-03-01 00:00:00

  • Double-blind, randomized, placebo-controlled pilot study of leflunomide in systemic lupus erythematosus.

    abstract::Twelve systemic lupus erythematosus (SLE) patients with mild to moderate disease activity (SLEDAI of > or = 6 and on prednisolone < 0.5 mg/kg/day) were included in a prospective, randomized, double-blind, placebo-controlled pilot study for 24 weeks. Six were randomized to receive oral leflunomide and six received plac...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/0961203304lu1067sr

    authors: Tam LS,Li EK,Wong CK,Lam CW,Szeto CC

    更新日期:2004-01-01 00:00:00

  • Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand.

    abstract:Background:Strongyloidiasis can be fatal in systemic lupus erythematosus (SLE) patients, but few epidemiological studies have investigated the burden of this tropical disease among the SLE population. This study aimed to assess the prevalence and associated factors of strongyloidiasis among SLE patients in Southern Tha...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320911091

    authors: Juthong S,Geater AF,Dekumyoy P,Hortiwakul T,Siripaitoon B,Aiewruengsurat D,Thongbun N

    更新日期:2020-05-01 00:00:00

  • Autoantibodies in systemic lupus erythematosus: comparison of historical and current assessment of seropositivity.

    abstract::Systemic lupus erythematosus (SLE) is characterized by multiple autoantibodies and complement activation. Recent studies have suggested that anti-nuclear antibody (ANA) positivity may disappear over time in some SLE patients. Anti-double-stranded DNA (dsDNA) antibody titers and complement levels may vary with time and...

    journal_title:Lupus

    pub_type: 历史文章,杂志文章

    doi:10.1177/0961203310385738

    authors: Ippolito A,Wallace DJ,Gladman D,Fortin PR,Urowitz M,Werth V,Costner M,Gordon C,Alarcón GS,Ramsey-Goldman R,Maddison P,Clarke A,Bernatsky S,Manzi S,Bae SC,Merrill JT,Ginzler E,Hanly JG,Nived O,Sturfelt G,Sanchez-Gu

    更新日期:2011-03-01 00:00:00

  • Catastrophic antiphospholipid syndrome complicating orthotopic liver transplantation.

    abstract::Catastrophic antiphospholipid syndrome (CAPS) is an acutely devastating situation characterized by widespread thrombotic microangiopathy in the presence of elevated titers of antiphospholipid antibodies. We describe a 57-year old woman who underwent liver transplantation for primary sclerosing cholangitis and develope...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu278cr

    authors: Villamil A,Sorkin E,Basta MC,Mysler E,Macias S,Pekolj J,Ciardullo M,Eleta F,de Santibañes E,Allievi A,Gadano A

    更新日期:2003-01-01 00:00:00

  • Chinese Systemic Lupus Erythematosus Treatment and Research Group (CSTAR) Registry XI: gender impact on long-term outcomes.

    abstract:OBJECTIVE:The objective of this paper is to assess the role of gender on survival rate and causes of death and organ damage in systemic lupus erythematosus (SLE) patients in China from 2009 to 2015. METHODS:We conducted a multicenter cohort study to analyze the differences in outcome data between male and female SLE p...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203319839845

    authors: Zhang S,Ye Z,Li C,Li Z,Li X,Wu L,Liu S,Zuo X,Zhu P,Wang Z,Wang Y,Wang Z,Zhao J,Wang Q,Tian X,Li M,Zeng X

    更新日期:2019-04-01 00:00:00

  • Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis.

    abstract:BACKGROUND:Plasma mycophenolic acid (MPA) concentrations may predict therapeutic response in active lupus nephritis (LN). We determined the efficacy and safety of a concentration-controlled MPA regime in the treatment of severely active LN. METHODS:In this prospective study, 19 biopsy-proven class III/IV LN patients w...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1177/0961203313486949

    authors: Kittanamongkolchai W,Rukrung C,Supasiri T,Lertjirachai I,Somparn P,Chariyavilaskul P,Avihingsanon Y

    更新日期:2013-06-01 00:00:00

  • Lupus anticoagulant-hypoprothrombinemia syndrome: report of two cases and review of the literature.

    abstract::Lupus anticoagulant-hypoprothrombinemia syndrome (LA-HPS) is a rare acquired disorder caused by prothrombin antibodies. The disease is most common in the pediatric age group (<16 years), and more prevalent in women. There are well-established clinical diseases associated with LA-HPS, most notably systemic lupus erythe...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314558859

    authors: Mulliez SM,De Keyser F,Verbist C,Vantilborgh A,Wijns W,Beukinga I,Devreese KM

    更新日期:2015-06-01 00:00:00

  • Allergic disorders in systemic lupus erythematosus.

    abstract::Allergic disorders commonly occur in patients with systemic lupus erythematosus (SLE) and allergies to some drugs may occasionally be related to disease flares. We evaluated the prevalence of several types of allergy in 132 patients with SLE and their families and compared the SLE patients with a control group of 66 p...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200311

    authors: Sequeira JF,Cesic D,Keser G,Bukelica M,Karanagnostis S,Khamashta MA,Hughes GR

    更新日期:1993-06-01 00:00:00

  • Infections in infancy and the presence of antinuclear antibodies in adult life.

    abstract::There has been limited success defining environmental factors important to the development of connective tissue diseases such as systemic lupus erythematosus (SLE). Recent work has suggested that the perinatal environment may be important. To investigate this we measured antinuclear antibodies (ANA) in a general popul...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203306lu2286oa

    authors: Edwards CJ,Syddall H,Goswami R,Goswami P,Dennison EM,Cooper C

    更新日期:2006-01-01 00:00:00

  • Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.

    abstract::Anti-phospholipid antibodies are common in patients in the Hopkins' Lupus Cohort: 47% have anti-cardiolipin, 32.5% anti-beta(2)-glycoprotein I and 26% lupus anticoagulant (by dRVVT confirmatory testing). Systemic lupus erythematosus patients with the lupus anticoagulant at baseline have a 50% chance of a deep venous t...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309360541

    authors: Petri M

    更新日期:2010-04-01 00:00:00

  • Hypertension as the presenting feature of the antiphospholipid syndrome.

    abstract::The antiphospholipid or Hughes syndrome is the association between antiphospholipid antibodies (aPL), venous and arterial thromboses and pregnancy morbidity. Antiphospholipid syndrome (APS) commonly coexists with autoimmune diseases usually systemic lupus erythematosus (SLE), when it is known as secondary APS. When pr...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203302lu179cr

    authors: Karim MY,Alba P,Tungekar MF,Abbs IC,Khamashta MA,Hughes GR,Hunt BJ

    更新日期:2002-01-01 00:00:00